Evogliptin
From Infogalactic: the planetary knowledge core
Evogliptin (trade name Suganon, previously identified as DA-1229, Dong-A ST) is an antidiabetic drug in the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.[1] It was developed by the South Korean pharmaceutical company Dong-A.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
